Hyaluronic acid filler for skin quality on GLP-1 users
Part of Genetic & congenital, Skin clinical trials.
This trial tests whether a hyaluronic acid filler (a gel injected into the skin) can improve skin quality in women who are taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to see if the filler helps with skin radiance, elasticity, tone, firmness, fine lines, wrinkles, and smoothness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Women between the ages of 25 and 50 years old.
- You have moderate skin changes (not too mild or too severe) in areas like brightness, firmness, and fine lines.
- You are either currently taking a GLP-1 medication (like Ozempic) at a stable dose for at least 6 months, or you have not taken any GLP-1 medication in the last year.
- Your weight has been stable (no more than a 10% change recently) and your body mass index (BMI) is 27 or lower.
- You are willing to keep the same skincare routine and not have other cosmetic treatments on your face during the study.
- You are not pregnant, planning pregnancy, or breastfeeding, and if you could become pregnant, you agree to use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a hyaluronic acid gel filler to restore lost volume and smooth fine lines in the face. It may help if you have mild-to-moderate aging in your cheeks or around your nose and mouth and have not had other facial treatments recently.
This trial tests a new injectable filler made from hyaluronic acid and recombinant collagen to smooth wrinkles and add volume. It may help people who want a non-surgical option for facial rejuvenation.
This study tests whether injections of poly-L-lactic acid (a collagen-boosting filler) can improve loose skin on the belly in women taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to help people who have mild to moderate loose skin and are at a stable weight.
This study tests a new facial serum (AGE Serum) designed to improve signs of aging like fine lines and loose skin in post-menopausal women who are taking GLP-1 medications (like Ozempic or Wegovy). Researchers want to see if it's safe and if it actually works to improve how the skin looks.
This study tests a topical serum designed to improve visible signs of facial aging, such as fine lines and skin texture. It is looking specifically at men and women aged 25–50 who are already taking a GLP-1 medication like Ozempic, and want to see if adding this serum helps their skin look younger.
This trial tests whether a facial filler called Radiesse can restore volume lost during weight loss from GLP-1 medications (like Wegovy or Mounjaro). It's for adults just starting GLP-1 therapy who expect to lose 20 pounds or more and want to see if fillers can help their face look fuller.
Hear when a new Wrinkle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.